| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abuse Potential of Pregabalin
|
Schjerning, Ole
|
|
2016
|
|
1 |
p. 9-25
|
artikel
|
| 2 |
Activating Autophagy as a Therapeutic Strategy for Parkinson’s Disease
|
Fowler, Alan J.
|
|
2018
|
|
1 |
p. 1-11
|
artikel
|
| 3 |
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
|
Berger, Thomas
|
|
2016
|
|
1 |
p. 33-50
|
artikel
|
| 4 |
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
|
Berger, Thomas
|
|
2017
|
|
1 |
p. 33-50
|
artikel
|
| 5 |
Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study
|
Sutter, Raoul
|
|
2016
|
|
1 |
p. 65-74
|
artikel
|
| 6 |
Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study
|
Sutter, Raoul
|
|
|
|
1 |
p. 65-74
|
artikel
|
| 7 |
Antidepressant Class, Age, and the Risk of Deliberate Self-Harm: A Propensity Score Matched Cohort Study of SSRI and SNRI Users in the USA
|
Miller, Matthew
|
|
2013
|
|
1 |
p. 79-88
|
artikel
|
| 8 |
Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study
|
Weinstock-Guttman, Bianca
|
|
2017
|
|
1 |
p. 75-84
|
artikel
|
| 9 |
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine
|
Hobart, Jeremy
|
|
2018
|
|
1 |
p. 61-79
|
artikel
|
| 10 |
A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia
|
Harvey, Rebecca C.
|
|
2016
|
|
1 |
p. 27-39
|
artikel
|
| 11 |
Authors’ Reply to Ulrich: Comment on ‘Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use Them Safely and Effectively’
|
Baldwin, David S.
|
|
|
|
1 |
p. 103
|
artikel
|
| 12 |
A 10-Year Observational Study of the Use, Acceptability and Effectiveness of Long-Acting Paliperidone Palmitate: Implications for Clinical Decision Making
|
Pappa, Sofia
|
|
|
|
1 |
p. 107-116
|
artikel
|
| 13 |
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain
|
Petzke, Frank
|
|
|
|
1 |
p. 31-44
|
artikel
|
| 14 |
Carbidopa/Levodopa ER Capsules (Rytary®, Numient™): A Review in Parkinson’s Disease
|
Greig, Sarah L.
|
|
2015
|
|
1 |
p. 79-90
|
artikel
|
| 15 |
Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials
|
Meskill, Gerard J.
|
|
|
|
1 |
p. 61-69
|
artikel
|
| 16 |
Clinically Significant Drug Interactions with Newer Antidepressants
|
Spina, Edoardo
|
|
2012
|
|
1 |
p. 39-67
|
artikel
|
| 17 |
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
|
Coghill, David R.
|
|
2018
|
|
1 |
p. 85-95
|
artikel
|
| 18 |
Comment on: “Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively”
|
Ulrich, Sven
|
|
|
|
1 |
p. 101-102
|
artikel
|
| 19 |
Continuous Drug Delivery in Parkinson’s Disease
|
Senek, Marina
|
|
2013
|
|
1 |
p. 19-27
|
artikel
|
| 20 |
Correction to: Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
|
Chamberlain, Samuel R.
|
|
|
|
1 |
p. 97
|
artikel
|
| 21 |
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
|
Hoy, Sheridan M.
|
|
|
|
1 |
p. 99
|
artikel
|
| 22 |
Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use
|
Frampton, James E.
|
|
|
|
1 |
p. 135
|
artikel
|
| 23 |
Correction to: Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis
|
Papadopoulos, Dimitrios
|
|
2018
|
|
1 |
p. 93-97
|
artikel
|
| 24 |
Correction to: Siponimod: A Review in Secondary Progressive Multiple Sclerosis
|
Scott, Lesley J.
|
|
|
|
1 |
p. 133
|
artikel
|
| 25 |
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis
|
Zhang, Xinke
|
|
2014
|
|
1 |
p. 71-81
|
artikel
|
| 26 |
Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome
|
Quezada, Julio
|
|
2018
|
|
1 |
p. 33-45
|
artikel
|
| 27 |
Defining the Role of Baclofen for the Treatment of Alcohol Dependence
|
Muzyk, Andrew J.
|
|
2012
|
|
1 |
p. 69-78
|
artikel
|
| 28 |
Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain–Barré Syndrome and Narcolepsy
|
Stowe, Julia
|
|
|
|
1 |
p. 1-8
|
artikel
|
| 29 |
Drug Repositioning: Playing Dirty to Kill Pain
|
Bastos, Leandro Francisco Silva
|
|
2013
|
|
1 |
p. 45-61
|
artikel
|
| 30 |
Early Morning ADHD Symptoms and Functional Impairment: Impact on Patients and Caregivers, and Pharmacological Approaches to Management
|
Childress, Ann C.
|
|
|
|
1 |
p. 31-44
|
artikel
|
| 31 |
Effect of Levetiracetam on Cognition: A Systematic Review and Meta-analysis of Double-Blind Randomized Placebo-Controlled Trials
|
Lin, Chia-Yen
|
|
|
|
1 |
p. 1-14
|
artikel
|
| 32 |
Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility
|
Every-Palmer, Susanna
|
|
2018
|
|
1 |
p. 81-91
|
artikel
|
| 33 |
Efficacy and Safety of Ibuprofen Plus Paracetamol in a Fixed-Dose Combination for Acute Postoperative Pain in Adults: Meta-Analysis and a Trial Sequential Analysis
|
Abushanab, Dina
|
|
|
|
1 |
p. 105-120
|
artikel
|
| 34 |
Emergency and Critical Care Management of Acute Ischaemic Stroke
|
Figueroa, Stephen A.
|
|
2014
|
|
1 |
p. 17-28
|
artikel
|
| 35 |
Emerging Targets in Migraine
|
Hoffmann, Jan
|
|
2013
|
|
1 |
p. 11-17
|
artikel
|
| 36 |
Erratum to: Modafinil: a review of its pharmacology and clinical efficacy in the management of narcolepsy
|
McClellan, KJ
|
|
1998
|
|
1 |
p. 59
|
artikel
|
| 37 |
Erratum to Zolmitriptan
|
Palmer, K. J.
|
|
1997
|
|
1 |
p. 11
|
artikel
|
| 38 |
Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies
|
Strzelczyk, Adam
|
|
|
|
1 |
p. 61-83
|
artikel
|
| 39 |
Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
|
Li, Xin
|
|
|
|
1 |
p. 55-65
|
artikel
|
| 40 |
Fatigue in Patients with Major Depressive Disorder: Prevalence, Burden and Pharmacological Approaches to Management
|
Ghanean, Helia
|
|
2018
|
|
1 |
p. 65-74
|
artikel
|
| 41 |
Generic Products of Antiepileptic Drugs: A Perspective on Bioequivalence, Bioavailability, and Formulation Switches Using Monte Carlo Simulations
|
Karalis, Vangelis
|
|
2013
|
|
1 |
p. 69-77
|
artikel
|
| 42 |
Glycogen Synthase Kinase-3 as a Therapeutic Target for Cognitive Dysfunction in Neuropsychiatric Disorders
|
O’Leary, Olivia
|
|
2014
|
|
1 |
p. 1-15
|
artikel
|
| 43 |
Impact of Antidepressant Use on the Trajectory of Alzheimer’s Disease: Evidence, Mechanisms, and Therapeutic Implications
|
Khoury, Rita
|
|
2018
|
|
1 |
p. 17-29
|
artikel
|
| 44 |
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study
|
Palmeri, Serena
|
|
|
|
1 |
p. 83-96
|
artikel
|
| 45 |
Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases
|
Gage, Meghan C.
|
|
|
|
1 |
p. 1-20
|
artikel
|
| 46 |
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia
|
Zhuo, Chuanjun
|
|
|
|
1 |
p. 33-44
|
artikel
|
| 47 |
Intranasal Insulin for Alzheimer’s Disease
|
Hallschmid, Manfred
|
|
|
|
1 |
p. 21-37
|
artikel
|
| 48 |
Intranasal Medications for the Treatment of Migraine and Cluster Headache
|
Rapoport, Alan M.
|
|
|
|
1 |
p. 37-46
|
artikel
|
| 49 |
Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia
|
Mould, Arne W.
|
|
|
|
1 |
p. 1-16
|
artikel
|
| 50 |
Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases
|
Wilcox, Jessica A.
|
|
|
|
1 |
p. 45-67
|
artikel
|
| 51 |
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
|
Kunz, Dieter
|
|
|
|
1 |
p. 93-106
|
artikel
|
| 52 |
Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
|
Sands, Tristan T.
|
|
2018
|
|
1 |
p. 47-60
|
artikel
|
| 53 |
Medication Adherence in Patients with Parkinson’s Disease
|
Malek, Naveed
|
|
2014
|
|
1 |
p. 47-53
|
artikel
|
| 54 |
Melatonin in Cluster Headache
|
Leone, Massimo
|
|
|
|
1 |
p. 7-16
|
artikel
|
| 55 |
Mitochondrial Enhancement for Neurodegenerative Movement Disorders: A Systematic Review of Trials Involving Creatine, Coenzyme Q10, Idebenone and Mitoquinone
|
Liu, Jia
|
|
2013
|
|
1 |
p. 63-68
|
artikel
|
| 56 |
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
|
Ling, Susan
|
|
|
|
1 |
p. 17-30
|
artikel
|
| 57 |
Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis
|
Gensicke, Henrik
|
|
2012
|
|
1 |
p. 11-37
|
artikel
|
| 58 |
Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment
|
Jakimovski, Dejan
|
|
|
|
1 |
p. 45-59
|
artikel
|
| 59 |
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future
|
Crisafulli, Salvatore
|
|
|
|
1 |
p. 15-32
|
artikel
|
| 60 |
Neurocysticercosis
|
Sotelo, Julio
|
|
|
|
1 |
p. 17-25
|
artikel
|
| 61 |
New Non-Intravenous Routes for Benzodiazepines in Epilepsy: A Clinician Perspective
|
Mula, Marco
|
|
2016
|
|
1 |
p. 11-17
|
artikel
|
| 62 |
Opicapone: A Review in Parkinson’s Disease
|
Scott, Lesley J.
|
|
|
|
1 |
p. 121-131
|
artikel
|
| 63 |
Opioidergic Agents as Antidepressants: Rationale and Promise
|
Saxena, Parnika P.
|
|
2018
|
|
1 |
p. 9-16
|
artikel
|
| 64 |
Oral Contraceptives and Stroke
|
Lidegaard, Øjvind
|
|
|
|
1 |
p. 1-5
|
artikel
|
| 65 |
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies
|
Fagan, Harry
|
|
|
|
1 |
p. 1-12
|
artikel
|
| 66 |
Outpatient Pharmacotherapy and Modes of Administration for Acute Repetitive and Prolonged Seizures
|
McKee, Heather Ravvin
|
|
2015
|
|
1 |
p. 55-70
|
artikel
|
| 67 |
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
|
Correll, Christoph U.
|
|
|
|
1 |
p. 39-59
|
artikel
|
| 68 |
Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion
|
Cook, Aaron M.
|
|
2015
|
|
1 |
p. 71-77
|
artikel
|
| 69 |
Pharmacokinetics, Drug Interactions and Exposure-Response Relationship of Eslicarbazepine Acetate in Adult Patients with Partial-Onset Seizures
|
Falcão, Amilcar
|
|
2012
|
|
1 |
p. 79-91
|
artikel
|
| 70 |
Pharmacokinetics, Safety, and Tolerability of SHP465 Mixed Amphetamine Salts After Administration of Multiple Daily Doses in Children Aged 4–5 Years with Attention-Deficit/Hyperactivity Disorder
|
Ilic, Katarina
|
|
|
|
1 |
p. 71-81
|
artikel
|
| 71 |
Pharmacological Interventions for the Treatment of Smokeless Tobacco Use
|
Ebbert, Jon O.
|
|
2012
|
|
1 |
p. 1-10
|
artikel
|
| 72 |
Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention
|
Kamal, Rama M.
|
|
2016
|
|
1 |
p. 51-64
|
artikel
|
| 73 |
Post-Injection Delirium/Sedation Syndrome in Patients Treated with Olanzapine Pamoate: Mechanism, Incidence, and Management
|
Luedecke, Daniel
|
|
2014
|
|
1 |
p. 41-46
|
artikel
|
| 74 |
Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa
|
McElroy, Susan L.
|
|
2018
|
|
1 |
p. 31-46
|
artikel
|
| 75 |
Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later
|
Awad, A. George
|
|
2018
|
|
1 |
p. 1-8
|
artikel
|
| 76 |
Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications
|
Anderson, George
|
|
2013
|
|
1 |
p. 1-10
|
artikel
|
| 77 |
Role of Inositol in the Treatment of Psychiatric Disorders
|
Vadnal, Robert
|
|
|
|
1 |
p. 6-16
|
artikel
|
| 78 |
Role of Viral Infection in the Aetiology of Multiple Sclerosis
|
Berti, Rossana
|
|
|
|
1 |
p. 1-7
|
artikel
|
| 79 |
Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke
|
Gulati, Anil
|
|
|
|
1 |
p. 85-104
|
artikel
|
| 80 |
Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression
|
Watanabe, Norio
|
|
2010
|
|
1 |
p. 35-53
|
artikel
|
| 81 |
Sedation in Critically Ill Patients
|
Gravel, Normand R.
|
|
|
|
1 |
p. 9-22
|
artikel
|
| 82 |
Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status
|
Ferrero, Hilda
|
|
2016
|
|
1 |
p. 19-32
|
artikel
|
| 83 |
Systematic Review of Combined Pharmacotherapy for the Treatment of Alcohol Use Disorder in Patients Without Comorbid Conditions
|
Naglich, Andrew C.
|
|
2017
|
|
1 |
p. 13-31
|
artikel
|
| 84 |
Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
|
Chan, Andrew
|
|
2016
|
|
1 |
p. 41-51
|
artikel
|
| 85 |
The Benzodiazepine–Dementia Disorders Link: Current State of Knowledge
|
Pariente, Antoine
|
|
2015
|
|
1 |
p. 1-7
|
artikel
|
| 86 |
The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review
|
Gates, Thomas M.
|
|
2016
|
|
1 |
p. 53-69
|
artikel
|
| 87 |
The Glutamate Hypothesis of Schizophrenia
|
Ishimaru, Masahiko J.
|
|
|
|
1 |
p. 47-67
|
artikel
|
| 88 |
The Impact of Medication on Health-Related Quality of Life in Patients with Generalized Anxiety Disorder
|
Wilson, Hilary
|
|
2014
|
|
1 |
p. 29-40
|
artikel
|
| 89 |
The Pharmacology of Imepitoin: The First Partial Benzodiazepine Receptor Agonist Developed for the Treatment of Epilepsy
|
Rundfeldt, Chris
|
|
2013
|
|
1 |
p. 29-43
|
artikel
|
| 90 |
The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study
|
Every-Palmer, Susanna
|
|
2016
|
|
1 |
p. 75-85
|
artikel
|
| 91 |
Therapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke
|
Appleton, Jason P.
|
|
2016
|
|
1 |
p. 1-9
|
artikel
|
| 92 |
Thrombolysis with Recombinant Human Prourokinase 4.5–6 h After Acute Ischemic Stroke: A Phase IIa, Randomized, and Open-Label Multicenter Clinical Trial
|
Song, Haiqing
|
|
|
|
1 |
p. 67-75
|
artikel
|
| 93 |
Treatment of Patients with Multiple Sclerosis Transitioning Between Relapsing and Progressive Disease
|
Dimitriou, Nikolaos G.
|
|
|
|
1 |
p. 69-92
|
artikel
|
| 94 |
Treatment of Sleep, Motor and Sensory Symptoms with the Orexin Antagonist Suvorexant in Adults with Idiopathic Restless Legs Syndrome: A Randomized Double-Blind Crossover Proof-of-Concept Study
|
Garcia-Borreguero, Diego
|
|
|
|
1 |
p. 45-54
|
artikel
|
| 95 |
Treatment Outcomes of Newly Diagnosed Epilepsy: A Systematic Review and Meta-analysis
|
Janmohamed, Mubeen
|
|
|
|
1 |
p. 13-30
|
artikel
|
| 96 |
Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence
|
Jönsson, Anna K.
|
|
2018
|
|
1 |
p. 47-64
|
artikel
|
Tijdschrift beschrijving